← Back
Data updated: Mar 10, 2026
NANG KUANG PHARM CO
OncologyInfectious DiseaseDermatology
NANG KUANG PHARM CO is a generic drug manufacturer focused on Oncology, Infectious Disease, Dermatology. Key products include PEMETREXED DISODIUM.
2016
Since
5
Drugs
-
Trials
76
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
IBANDRONATE SODIUM 2026-02-03
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 33%
1 drugs
Infectious Disease 33%
1 drugs
Dermatology 33%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Dermatology
Baxter specialty
Infectious Disease, Oncology, Dermatology
COSETTE other
Dermatology, Infectious Disease, Oncology
KING PHARMS LLC big-pharma
Infectious Disease, Dermatology, Oncology
FOUGERA PHARMS other
Dermatology, Infectious Disease, Oncology
Discontinued (0)
Company Info
- First Approval
- 2016-12-20
- Latest
- 2026-02-03
- Applications
- 5